VA-REGULA
5.6.2024 08:31:32 CEST | Business Wire | Press release
Access to international festivals like Sziget and Untold, which draw up to 100,000 visitors daily, has been significantly enhanced. Regula, a global developer of forensic devices and identity verification solutions, and Netpositive, a Hungarian IT service provider specializing in large-scale event management, joined forces to switch to mobile ID verification (IDV) via a special app empowered by IDV software. As a result, Netpositive’s state-of-the-art Backstage Ticketing ecosystem has become an even more valuable asset for event organizers across the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604833546/en/
Netpositive’s new Backstage Ticketing solution for large events’ visitor ID verification based on Regula Document Reader SDK (Graphic: Business Wire)
The backbone of access services to large-scale events is the so-called “redemption” process, during which visitor tickets are checked and exchanged for wristbands with designated access rights. For this process to function properly, it is necessary to identify event visitors by their identity documents.
Netpositive used to handle document verification with the help of designated ID scanners provided by a third-party vendor. Apart from that, the company also employed a range of other devices, such as barcode readers, NFC readers, and laptops. The complexity of managing these devices often led to inefficiencies at event redemption points.
To make the process more productive and streamlined, Netpositive decided to switch to mobile ID verification (IDV) via a special app empowered by IDV software. After performing extensive research and following a partner’s recommendation, Netpositive opted for Regula Document Reader SDK, a comprehensive identity document verification software solution. Within one month, Regula’s solution was seamlessly built into Netpositive’s Backstage Ticketing Access Management App and integrated into their larger ecosystem, where they manage everything from ticket sales to redemption checks to event dashboards.
Regula Document Reader SDK allows Netpositive’s Backstage Ticketing ecosystem to read and verify passports, ID cards, and driver’s licenses with a single mobile device. Not only does Regula’s solution speed up the document check process, but it also enhances security by performing cross-checks to identify any data discrepancies that could indicate fraud. Apart from that, Regula Document Reader SDK re-verifies biometric documents on the server side in the customer’s secure perimeter in order to ensure that the chip is genuine and its data has not been cloned or manipulated, and thus prevent sophisticated fraud. The solution's extensive document template database includes over 13,900 templates from 249 countries and territories, ensuring comprehensive coverage and seamless processing for international event attendees.
Implementing Regula’s technology has already shown remarkable success at recent events, such as Untold Dubai, visited by over 185,000 people, and Massif in Romania, with a capacity of 12,000 people per day. The streamlined mobile solution has reduced queues, cut down manual labor, and received overwhelmingly positive feedback from staff and attendees alike.
In the long run, Netpositive expects to cut expenses on device procurement, and expects to significantly reduce the number of technical problems involved with the redemption process, which were relatively frequent with the previous solution.
“We are still at an early stage of the access admission process transformation, and we assume we will get more tangible results during the coming season of summer festivals. But we are very sure of one thing: with this new solution with the Regula Document Reader SDK at the core, we made a real innovation. The reinvention of the redemption process helped us become more competitive, promoting our position in the market,” says Mátyás Török, Netpositive’s founder and CEO.
"Our collaboration with Netpositive not only showcases the importance of robust and efficient identity verification, but also sets a new standard for access management in large-scale events. We are proud to contribute to creating safer and more efficient event experiences around the globe," says Ihar Kliashchou, Chief Technology Officer at Regula.
For more information on how Netpositive is transforming event access management with Regula’s IDV solutions, read the success story.
About Netpositive
Netpositive creates large-scale, unique, load-proof digital solutions. With more than 50 partners, 500 international events, and 36 million unique users, it became Central Europe's leading event IT service provider during the last 10 years. You can meet its staff and its self-developed Backstage Ticketing ecosystem at several domestic and international events, including award-winning music festivals like Sziget (HU) and Untold (RO).
Learn more at www.netpositive.hu.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security or speed. Regula was repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604833546/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
